Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhonghua Lin

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Journal of Medicinal Chemistry|April 7, 2015
Tetrahydroindazoles as Interleukin-2 Inducible T-Cell Kinase Inhibitors. Part II. Second-Generation Analogues with Enhanced Potency, Selectivity, and Pharmacodynamic Modulation in VivoJason D Burch, Kathy Barrett, Yuan Chen, et al.
Scientific Reports|May 10, 2018
A targeted boost-and-sort immunization strategy using Escherichia coli BamA identifies rare growth inhibitory antibodiesRajesh Vij, Zhonghua Lin, Nancy Chiang, et al.
JCI Insight|October 5, 2016
Depletion of major pathogenic cells in asthma by targeting CRTh2Tao Huang, Meredith Hazen, Yonglei Shang, et al.
Blood|August 10, 2007
Anti-BR3 antibodies: a new class of B-cell immunotherapy combining cellular depletion and survival blockadeWei Yu Lin, Qian Gong, Dhaya Seshasayee, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 11, 2013
Polyclonal hyper-IgE mouse model reveals mechanistic insights into antibody class switch recombinationShahram Misaghi, Kate Senger, Tao Sai, et al.
The Journal of Clinical Investigation|May 12, 2010
Antibodies specific for a segment of human membrane IgE deplete IgE-producing B cells in humanized miceHans D Brightbill, Surinder Jeet, Zhonghua Lin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 18, 2014
PILRα negatively regulates mouse inflammatory arthritisYonglian Sun, Patrick Caplazi, Juan Zhang, et al.
Science (New York, N.Y.)|August 11, 2012
Loss of the tumor suppressor BAP1 causes myeloid transformationAnwesha Dey, Dhaya Seshasayee, Rajkumar Noubade, et al.
Bioorganic & Medicinal Chemistry Letters|August 24, 2017
Identification of an imidazopyridine scaffold to generate potent and selective TYK2 inhibitors that demonstrate activity in an in vivo psoriasis modelJun Liang, Anne Van Abbema, Mercedesz Balazs, et al.
Nature|November 27, 2025
Author Correction: Inhibiting membrane rupture with NINJ1 antibodies limits tissue injuryNobuhiko Kayagaki, Irma B Stowe, Kamela Alegre, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Journal of Medicinal Chemistry|April 7, 2015
Tetrahydroindazoles as Interleukin-2 Inducible T-Cell Kinase Inhibitors. Part II. Second-Generation Analogues with Enhanced Potency, Selectivity, and Pharmacodynamic Modulation in VivoJason D Burch, Kathy Barrett, Yuan Chen, et al.
Scientific Reports|May 10, 2018
A targeted boost-and-sort immunization strategy using Escherichia coli BamA identifies rare growth inhibitory antibodiesRajesh Vij, Zhonghua Lin, Nancy Chiang, et al.
JCI Insight|October 5, 2016
Depletion of major pathogenic cells in asthma by targeting CRTh2Tao Huang, Meredith Hazen, Yonglei Shang, et al.
Blood|August 10, 2007
Anti-BR3 antibodies: a new class of B-cell immunotherapy combining cellular depletion and survival blockadeWei Yu Lin, Qian Gong, Dhaya Seshasayee, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 11, 2013
Polyclonal hyper-IgE mouse model reveals mechanistic insights into antibody class switch recombinationShahram Misaghi, Kate Senger, Tao Sai, et al.
The Journal of Clinical Investigation|May 12, 2010
Antibodies specific for a segment of human membrane IgE deplete IgE-producing B cells in humanized miceHans D Brightbill, Surinder Jeet, Zhonghua Lin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 18, 2014
PILRα negatively regulates mouse inflammatory arthritisYonglian Sun, Patrick Caplazi, Juan Zhang, et al.
Science (New York, N.Y.)|August 11, 2012
Loss of the tumor suppressor BAP1 causes myeloid transformationAnwesha Dey, Dhaya Seshasayee, Rajkumar Noubade, et al.
Bioorganic & Medicinal Chemistry Letters|August 24, 2017
Identification of an imidazopyridine scaffold to generate potent and selective TYK2 inhibitors that demonstrate activity in an in vivo psoriasis modelJun Liang, Anne Van Abbema, Mercedesz Balazs, et al.
Nature|November 27, 2025
Author Correction: Inhibiting membrane rupture with NINJ1 antibodies limits tissue injuryNobuhiko Kayagaki, Irma B Stowe, Kamela Alegre, et al.
Pageof 8